Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.

Document Type

Journal Article

Publication Date

2-1-2016

Journal

Arteriosclerosis, Thrombosis, and Vascular Biology

Volume

36

Issue

2

Inclusive Pages

418-24

DOI

10.1161/ATVBAHA.115.306905

Peer Reviewed

1

Share

COinS